WeVote
Log In

Bill

Bill

LB 1138

Provide an exemption from requirements for prescribers issuing prescriptions for controlled substances

108th Legislature (2023-2024) Introduced by Merv Riepe

LB 1138 would exempt certain Nebraska prescribers from controlled substance prescription requirements, but was indefinitely postponed after portions were absorbed into another bill.

Provisions/portions of LB1138 amended into LB1215 by AM2549
2
WeVote Research Nonpartisan
Bill Summary · LB 1138

Legislative bill overview

LB 1138 would exempt certain prescribers from existing requirements when issuing prescriptions for controlled substances in Nebraska. The bill was introduced in January 2024 but was indefinitely postponed in April, though portions were incorporated into another bill (LB 1215) through an amendment.

Why is this important

Controlled substance prescribing is heavily regulated at both state and federal levels to prevent drug abuse and diversion while ensuring patients can access necessary medications. Any exemptions from these requirements affect the balance between medical access and public safety, and can impact how healthcare providers operate and how regulators monitor prescription patterns.

Potential points of contention

  • Scope of exemptions unclear: The bill's specific exemptions aren't detailed in available records, making it difficult to assess whether they meaningfully address a genuine regulatory burden or potentially weaken safeguards
  • Regulatory oversight concerns: Exemptions from prescribing requirements could complicate enforcement efforts by the Nebraska Department of Health and Human Services and DEA
  • Patient safety vs. provider burden: Tension between reducing administrative burden on prescribers and maintaining systems designed to prevent drug misuse and addiction

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.